Biotechnology and Health
Session 1: Biomedical Engineering
Session Chair: Dr Mourad Salaheddine (Director - Animal Health and Production, PHARMING TECHNOLOGIES, Leiden, The Netherlands) and Prof Rabah Bakour (Université des Sciences et de la Technologie Houari Boumediene (USTHB), Faculté des Sciences Biologiques, Laboratoire de Biologie Cellulaire et Moléculaire, El-Alia, Bab-Ezzouar, Alger, Algerie).
13:30 – 13:45
Design goal of pedicle screw-based posterior dynamic stabilization for the treatment of abnormal spinal segment.
Missoum Moumene (DePuy Spine Inc., Raynham, MA, USA).
13:45 – 14:00
Apport De La Radiobioliogie Et De L’immunobiotechnologie Dans La Biodectection Des Venins De Scorpions Et De Leurs Biomolecules: Optimisation De L’immunotherapie.
Feriel Merouane Ladjouzi (Laboratoire de Biologie Cellulaire et Moléculaire, Faculté des Sciences Biologiques, USTHB « Houari Boumédienne » Bab Ezzouar, Alger, Algeria).
14:00– 14:15
Production of Recombinant Human C1 Inhibitor in Milk of Transgenic Rabbits.
Mourad Salaheddine (Director - Animal Health and Production, PHARMING TECHNOLOGIES, Leiden, The Netherlands)
14:15– 14:30
Identification par protéomique d’une nouvelle PLA2 isolée à partir du venin de Cerastes cerastes.
Fatah Chérifi (Laboratoire de Biologie Cellulaire et Moléculaire, Faculté des Sciences Biologiques, Université des Sciences et de la Technologie Houari Boumediene, BP 32, El –Alia Bab Ezzouar, 16111, Alger, Algeria).
14:30 – 14:45
New dithiolopyrrolone antibiotics produced through bioprocess engineering from a Saharan actinomycete (Saccharothrix algeriensis NRRL B-24137).
Noureddine Bouras (École Normale Supérieure de Kouba, Laboratoire de Recherche sur les Produits Bioactifs et la Valorisation de la Biomasse, B.P. 92, 16 050 Vieux-Kouba, Alger, Algeria).
14:45 – 15:00 General Discussion
15:00 – 15:30 Coffee Break
Session 2: Drug Discovery
Session Chair: Dr Mohammed Dehbi (Head, Biochemistry and Molecular Biology Unit, Department of Biomedical Research, Dasman Institute for Research, Education & Prevention of Diabetes & Related Chronic Conditions, Kuwait) and Prof Mustapha Benboubetra (Centre for Genome-based Therapeutics, Welsh School of Pharmacy, Cardiff University, Cardiff, UK).
15:30 – 15:45
NEMO dependent regulation of HIV-1 Env induced cell fusion and autophagy.
Mehdi Bourouba (Laboratoire de Biologie cellulaire et moléculaire, Faculté de Biologie Université Houari Boumediene USTHB, BP32 EL Alia, 16111 Bab-Ezzouar, Alger).
15:45 – 16:00
Le traitement ex vivo des cpe avec sdf-1 avant transplantation pourrait augmenter leur potentiel proangiogene.
Fouzia Zemani (Laboratoire De Génétique Moléculaire Et Cellulaire, Usto, Oran, Algerie).
16:00 – 16:15
Transcriptional effects of delivery systems: the effect of dendrimer architecture on EGFR mRNA expression and on siRNA-mediated gene silencing activity.
Mustapha Benboubetra (Centre for Genome-based Therapeutics, Welsh School of Pharmacy, Cardiff University, Cardiff, UK).
16:15 – 16:30
The bacterial transcription machinery is an attractive target for antibiotics drug discovery.
Mohammed Dehbi (Head, Biochemistry and Molecular Biology Unit, Department of Biomedical Research, Dasman Institute for Research, Education & Prevention of Diabetes & Related Chronic Conditions, Kuwait).
16:30 – 16:45
Identification and characterization of new compounds of therapeutic or agronomic interest.
Mohammed Bellaoui (Université Mohammed Premier, Faculté des Sciences, Département de Biologie, Laboratoire de Génétique et Biotechnologies, Oujda 60000, Morocco).
16:45 – 17:00 General Discussion
****************************************************************************
End of the Day
****************************************************************************
Tuesday April 27, 2010
Session 3: Cancer and Immunity
Session Chair: Dr Habib Boukerche (INSERM, Faculté de Médecine René Laënnec, Université Claude Bernard Lyon I, France) and Dr Said Dermime (Senior Scientist, Chairman of Department of Biomedical Research, Head of Immunology & Innovative Cell Therapy, Dasman Institute for Research, Education & Prevention of Diabetes & Related Chronic Conditions, Kuwait).
13:30 – 13:45
Discovery of metastasis genes by combining in vivo selection of human metastatic cells and Subtractive hybridization strategies.
Habib Boukerche (INSERM, Faculté de Médecine René Laënnec, Université Claude Bernard Lyon I, France).
13:45 – 14:00
The use of overlapping peptides encompassing the whole Wilms tumor antigen (WT1) to discover novel human CD4+ regulatory T cells important for immune escape of leukemia.
Said Dermime (Senior Scientist, Chairman of Department of Biomedical Research, Head of Immunology & Innovative Cell Therapy, Dasman Institute for Research, Education & Prevention of Diabetes & Related Chronic Conditions, Kuwait).
14:00 – 14:15
Implication pronostique des mutations du gène KRAS dans la prise en charge des cancers colorectaux métastatiques : Résultats préliminaires d’une étude Algérienne.
Kenza Berkane (Laboratoire d’Oncologie Moléculaire, Fondamentale et Appliquée (LOMFA).Service d’Oncologie Médicale, Centre Pierre & Marie Curie, Alger, ALGERIE.EHS/CPMC).
14:15 – 14:30
Signal Transduction in Chronic Lymphocytic Leukemia B –Lymphocytes.
Rasmi AbuHelu, (Dean, Faculty of Health Professions, Al-Quds University Main Campus, Abu-Deis, Jerusalem, WEST BANK).
14:30 – 14:45
Proteomics for new Biomarkers Discovery: towards early detection of Cancer.
Ali Tiss (Scientist/Proteomics Team Leader,Biochemistry and Molecular Biology Unit, Department of Biomedical Research, Dasman Institute for Research, Education & Prevention of Diabetes & Related Chronic Conditions, Kuwait).
14:45 – 15:00 General Discussion
15:00 – 15:30 Coffee Break
Session 4: Mechanisms of Diseases and Infection
Session Chair: Prof Chafia Touil (Directeur du laboratoire de Biologie Cellulaire et Moléculaire, Université Des Sciences Et De La Technologie Houari Boumediene-USTHB, Alger, Algérie) and Dr Yahia Chebloune (Research Director at CNRS, LAPM, Grenoble, France).
15:30 – 15:45
A novel mechanism of the involvement of the toll like receptor-2 in the induction of interleukin-15 by herpes simplex virus-1 that can be implicated for developing vaccines against infections.
Rasheed Ahmad (Scientist / Team Leader, Immunology & Innovative Cell Therapy Unit, Department of Biomedical Research, Dasman Institute for Research, Education & Prevention of Diabetes & Related Chronic Conditions, Kuwait).
15:45 – 16:00
Molecular Identification of Multi-drug Resistant Mycobacterium tuberculosis in Sudanese Patients.
Miskelyemen A. Elmekki (College of Medical Laboratory Science, Sudan University of Science and Technology, Khartoum, Sudan).
16:00 – 16:15
Evasion strategies of Echinococcus granulosus to Th1 host protective response during human infection: IFN-γ/NO design in anti-hydatic activity.
Amri Manel (Laboratory of Cellular and Molecular Biology, Faculty of Biological Science, USTHB, PB 32, El-Alia, 16111, Algiers, Algeria).
16:15 – 16:30
Diagnosis of Visceral Leishmaniasis: Challenges and future aspects.
Sanjay Kumar, Aditya Singh Pratihar (Department of Biotechnology, Dayanand Academy of Management Studies (DAMS), Govind Nagar, Kanpur, U.P, India).
16:30 – 16:45
Pulmonary Nocardiosis; Similarity to Tuberculosis (A Bacteriological and Proteomics Study).
Mogahid M. El Hassan (College of Medical Laboratory Sciences, Sudan University of Science and Technology, Khartoum, Sudan).
16:45 – 17:00 General Discussion
****************************************************************************
End of the Day
****************************************************************************
Wednesday April 28, 2010
Session 5: Measuring Burden of Diseases
Session Chair: Dr Benabbas Youcef (Clinique de médecine interne- CHU Constantine, Algeria) and Prof Said Benallaoua (Directeur de Recherche, laboratoire de Biochimie Microbienne, Université de Béjaia, Algerie).
13:30 – 13:45
Preliminary results of risk factors characterization of type 2 diabetes (T2D) in Algerian population.
Soraya Benhamamouch(Département de Biotechnologie, Faculté des Sciences, Université d’Oran, Es-Sénia, Algeria).
13:45 – 14:00
Hyperuricemia: A cardiovascular risk factor in the diabetic patient.
Benabbas Youcef (Clinique de médecine interne- CHU Constantine, Algeria).
14:00 – 14:15
Morphological and molecular identification of mites and major allergens in house dusts from Algeria.
Mizab Leila (Laboratoire de Biologie Cellulaire et Moléculaire, Faculté des Sciences Biologiques (FSB). Université des Sciences et de la Technologie Houari Boumediene (USTHB), Algeria).
14:15 – 14:30
Familial Mediterranean fever: Molecular Exploration of MEFV gene among the Algerian population.
Djouher Ait Idir (Laboratoire de Biologie Cellulaire et Moléculaire, Faculté des Sciences Biologiques (FSB). Université des Sciences et de la Technologie Houari Boumediene (USTHB), Algeria).
14:30 – 14:45
Analyse Moléculaire Des Gènes Brca1 Et Brca2 Impliqués Dans La Survenue Du Cancer Du Sein Héréditaire Et/Ou Familial Dans Une Population De L’ouest Algérien.
Farida Taleb Bendiab (Laboratoire de Biologie du Développement et de la Differenciation. Departement de Biologie. Faculte des Sciences. Universite d’Oran Es-Senia, Algeria).
14:45 – 15:00 General Discussion
15:00 – 15:30 Coffee Break
Session 6: Novel Diagnostic Methods
Session Chair: Prof Hafida Merzouk (Faculté des Sciences, Département de Biologie, Laboratoire de Valorisation des actions de l’homme, Pour la protection de l’environnement et application en santé publique, Université Abou Bekr Belkaid de Tlemcen, Tlemcen, Algerie) and Dr Leila Laouar (Research Lab manager, Department of Orthopedic Surgery, University of Alberta, Canada).
15:30 – 15:45
Dosage du sélénium par voltamètrie cathodique inverse dans un échantillon d’individus sains, de l’ouest Algérien.
Nouria Edjati Née Dennouni (Universite De Tlemcen, Algeria).
15:45 – 16:00
Development of simple, rapid and very sensitive Molecular Detection method for laboratories and filed applications.
Ali Karami (Associate Professor of Molecular Biology Research Center of Molecular Biology, Baqiyatallah University of Medical Science, Tehran- IRAN).
16:00 – 16:15
Séparation Immunomagnétique des cellules B CD19+ et étude de la différenciation lymphocytaire B par cytométrie en flux.
Amel Boumendjel (Laboratoire de biochimie et microbiologie appliquées. Unité d’immunobiologie. Faculté des Sciences. Université Badji-Mokhtar, Annaba, Algérie).
16:15 – 16:30
Conception d'un kit de génotypage HLA-B27 par polymérisation en chaine de l'ADN en utilisant des amorces spécifiques de séquence (PCR-SSP).
Boudjema Abdallah (Laboratoire de Génétique Moléculaire et Cellulaire, Université des Sciences et de la Technologie d’Oran (USTO), Algérie).
16:30 – 16:45
WideScreen™ Assays for the Luminex® xMAP® Platform.
Fatima Lammali (Manager, Biosciences, Merck Chimie S.A.S. 201 rue Carnot F-94126 Fontenay sous Bois Cedex Capital social: 7.177.935 euros - FR 13 389 537 903 - RCS Créteil 389 537 903, France).
16:45 – 17:00 General Discussion
******************************************************************************
End of the Day
******************************************************************************